Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines?

Harold J. Burstein, Martine J. Piccart-Gebhart, Edith A. Perez, Gabriel N. Hortobagyi, Norman Wolmark, Kathy S. Albain, Larry Norton, Eric P. Winer, Clifford A. Hudis

Research output: Contribution to journalComment/debatepeer-review

33 Scopus citations
Original languageEnglish (US)
Pages (from-to)2179-2182
Number of pages4
JournalJournal of Clinical Oncology
Issue number18
StatePublished - Jun 20 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this